SEMAX
Synthetic ACTH-derived heptapeptide for neuroprotection and BDNF signaling research.
This lyophilized peptide must be reconstituted with RECON-S before use in research. Most customers forget to add it — don't get stuck waiting for a second order.
Add Reconstitution SolutionSemax (Met–Glu–His–Phe–Pro–Gly–Pro) is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Structurally derived from the ACTH(4–10) fragment of adrenocorticotropic hormone, it features a C-terminal Pro-Gly-Pro extension that confers enzymatic resistance and carries independent pharmacological activity beyond the ACTH-derived core.
Unlike the parent ACTH molecule, Semax does not stimulate adrenal steroidogenesis — its studied activity is confined to CNS-relevant signaling pathways.
